BA
CPIX icon

Bard Associates’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bard Associates’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-76,615
Closed -$488K – 167
2019
Q2 		$488K Sell
76,615
-500
-0.6% -$3.03K 0.24% 105
2019
Q1 		$448K Sell
77,115
-1,000
-1% -$5.8K 0.23% 110
2018
Q4 		$492K Sell
78,115
-1,000
-1% -$5.98K 0.28% 102
2018
Q3 		$452K Sell
79,115
-500
-0.6% -$2.95K 0.21% 118
2018
Q2 		$488K Sell
79,615
-3,600
-4% -$22.5K 0.23% 116
2018
Q1 		$556K Sell
83,215
-3,800
-4% -$26.2K 0.28% 106
2017
Q4 		$646K Sell
87,015
-1,300
-1% -$9.57K 0.31% 105
2017
Q3 		$624K Sell
88,315
-200
-0.2% -$1.38K 0.29% 105
2017
Q2 		$620K Sell
88,515
-50
-0.1% -$330 0.28% 107
2017
Q1 		$615K Sell
88,565
-3,950
-4% -$23.9K 0.29% 108
2016
Q4 		$509K Sell
92,515
-1,500
-2% -$7.82K 0.24% 107
2016
Q3 		$471K Sell
94,015
-300
-0.3% -$1.41K 0.23% 110
2016
Q2 		$424K Buy
94,315
+340
+0.4% +$1.56K 0.22% 115
2016
Q1 		$422K Buy
93,975
+15,350
+20% +$73.1K 0.24% 114
2015
Q4 		$414K Sell
78,625
-2,465
-3% -$14K 0.24% 108
2015
Q3 		$468K Sell
81,090
-1,400
-2% -$8.72K 0.27% 103
2015
Q2 		$590K Sell
82,490
-4,450
-5% -$30.9K 0.29% 97
2015
Q1 		$579K Sell
86,940
-1,800
-2% -$11.2K 0.28% 104
2014
Q4 		$531K Sell
88,740
-600
-0.7% -$3.08K 0.25% 113
2014
Q3 		$441K Sell
89,340
-75
-0.1% -$363 0.21% 121
2014
Q2 		$402K Sell
89,415
-1,900
-2% -$8.48K 0.16% 144
2014
Q1 		$411K Buy
91,315
+1,362
+2% +$6.48K 0.17% 138
2013
Q4 		$460K Sell
89,953
-1,350
-1% -$6.59K 0.19% 133
2013
Q3 		$414K Sell
91,303
-1,537
-2% -$7.65K 0.18% 138
2013
Q2 		$474K Buy
+92,840
New +$462K 0.22% 129

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bard Associates's CPIX Position: Q3 2019 in Review

Bard Associates sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2019, closing a stake of 76,615 shares — an estimated $488K sold.

Bard Associates first reported a position in CPIX in Q2 2013 and held it in 25 quarters. The position peaked at $646K in Q4 2017. 28 funds tracked by Wall St. Rank hold CPIX as of Q3 2019.

  • Bard Associates reported no remaining Cumberland Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Bard Associates sold 76,615 Cumberland Pharmaceuticals shares in Q3 2019, an estimated $488K.
  • Bard Associates first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 25 quarters.
  • Bard Associates's Cumberland Pharmaceuticals position peaked at $646K in Q4 2017.
  • 28 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2019.

Based on Bard Associates's 13F filing for Q3 2019, filed 14 Nov 2019.